XML 28 R7.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Preferred Stock
Common Stock
Additional Paid-In Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2022     4,975,000 690,334,422          
Beginning balance at Dec. 31, 2022 $ 52,582 $ 37 [1],[2] $ 0 $ 7 $ 34,725 $ 57,184 $ 37 [1],[2] $ (9,916) $ (29,418)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Comprehensive income (loss) 6,535         4,887   1,648  
Dividends—common stock (in shares) [3]       39,420          
Dividends—common stock [3] (931)     $ 0 4 (935)      
Dividends—preferred stock (228)         (228)      
Purchases of treasury stock (718)               (718)
Issuances of common stock and restricted stock, net of forfeitures (in shares)       5,731,927          
Issuances of common stock and restricted stock, net of forfeitures 299     $ 0 299        
Exercises of stock options (in shares)       136,899          
Exercises of stock options 10     $ 0 10        
Compensation expense for restricted stock units 503       503        
Ending balance (in shares) at Dec. 31, 2023     4,975,000 696,242,668          
Ending balance at Dec. 31, 2023 58,089 $ (25) [4] $ 0 $ 7 35,541 60,945 $ (25) [4] (8,268) (30,136)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Comprehensive income (loss) 3,732         4,750   (1,018)  
Dividends—common stock (in shares) [3]       38,319          
Dividends—common stock [3] (932)     $ 0 5 (937)      
Dividends—preferred stock (228)         (228)      
Purchases of treasury stock (734)               (734)
Issuances of common stock and restricted stock, net of forfeitures (in shares)       5,767,946          
Issuances of common stock and restricted stock, net of forfeitures 323     $ 0 323        
Exercises of stock options (in shares)       175,741          
Exercises of stock options 4     $ 0 4        
Compensation expense for restricted stock units 555       555        
Ending balance (in shares) at Dec. 31, 2024     4,975,000 702,224,674          
Ending balance at Dec. 31, 2024 60,784   $ 0 $ 7 36,428 64,505   (9,286) (30,870)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Comprehensive income (loss) 6,271         2,453   3,818  
Dividends—common stock (in shares) [3]       20,623          
Dividends—common stock [3] (1,516)     $ 0 4 (1,520)      
Dividends—preferred stock (252)         (252)      
Purchases of treasury stock (4,099)               (4,099)
Issuances of common stock and restricted stock, net of forfeitures (in shares)       6,170,041          
Issuances of common stock and restricted stock, net of forfeitures 400     $ 0 400        
Exercises of stock options (in shares)       131,043          
Exercises of stock options 9     $ 0 9        
Compensation expense for restricted stock units 743       743        
Reissuance of treasury stock related to the Transaction 50,586     $ 0 25,763       24,823
Issuances of preferred stock related to the Transaction (in shares)     10,700            
Issuances of preferred stock related to the Transaction 1,068   $ 0   1,068        
Redemptions of preferred stock (shares)     (5,000)            
Redemptions of preferred stock (500)   $ 0   (506) 6      
Purchase price allocation for restricted stock awards related to the Transaction 122       122        
Ending balance (in shares) at Dec. 31, 2025     4,980,700 708,546,381          
Ending balance at Dec. 31, 2025 $ 113,616   $ 0 $ 7 $ 64,031 $ 65,192   $ (5,468) $ (10,146)
[1] Impact from the adoption of ASU 2022-02, Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings (“TDR”) and Vintage Disclosures as of January 1, 2023.
[2] We have equity method investments in certain non-public entities which adopted ASU 2019-10, Financial Instruments - Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842) as of January 1, 2023. The impact to retained earnings was recorded in the second quarter of 2023, on a one quarter lag consistent with our standard operating procedures for equity method investments.
[3] We declared dividends per share on our common stock of $0.80 in the fourth quarter of 2025 and $0.60 per share for the first three quarters of 2025 and each quarter of 2024 and 2023.
[4] Impact from the adoption of ASU 2023-02, Investments - Equity Method and Joint Ventures (Topic 323): Accounting for Investments in Tax Credit Structures Using the Proportional Amortization Method as of January 1, 2024.